[Levonorgestrel releasing intrauterine spiral--contraception and therapeutic indications]

Praxis · 2001 · vol. 90(11) , pp. 442–52 · PMID:11293937 · W2461546112
Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-11 ⓘ

The levonorgestrel-releasing intrauterine system provides reliable contraception and reduces pelvic infection risks while treating hypermenorrhoea and dysmenorrhoea, serving as a therapeutic alternative to surgery for heavy menstrual bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The levonorgestrel-releasing intrauterine system (LNG-IUS) is a highly reliable contraceptive device. It is a suitable method of contraception also for breast-feeding mothers, and for women who have completed their family it is a real alternative to sterilisation. In comparison with the copper-releasing intrauterine devices, the rates of ectopic pregnancies and adnexitis/pelvic peritonitis (PID) are reduced. In menstruating women the menstrual blood loss is lower and, correspondingly, dysmenorrhoea and/or iron-deficiency anaemia occur less frequently and when they do occur they are less severe. In hypermenorrhoea/menorrhagia the LNG-IUS is a therapeutic alternative to the surgical procedure. In the menopause and postmenopause the LNG-IUS is suitable for protection of the endometrium in women undergoing continuous estrogen replacement therapy.

My notes (saved in your browser only)

Condition tags

dysmenorrhea

MeSH descriptors

Estrogen Replacement Therapy Intrauterine Devices, Medicated Levonorgestrel Menorrhagia Adult Aged Drug Therapy, Combination Female Humans Levonorgestrel Levonorgestrel Menorrhagia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:53.382863+00:00
License: CC0 · commercial use OK